Bain Capital Life Sciences Investors, LLC

Dicerna Pharmaceuticals Inc

10% Owner

Avg. Two Year Performance

271% Avg. Purchase Return 93% Compound

(103%) Avg. Sale Return (42%) Compound

Holdings: 5.58M shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions